Exploring the rare but serious risk of neurotuberculosis developing in patients treated with the biologic drug adalimumab
Exploring Africa's One Health strategy to combat infectious diseases and antimicrobial resistance through integrated human, animal, and environmental approaches.
How scientists are targeting the body's inflammatory signals to help more babies reach full term through cytokine signaling blockers.
Exploring how dimethyl fumarate, an approved multiple sclerosis treatment, shows promise for protecting brains from HIV-related oxidative stress and cognitive decline.
How a puzzling post-pandemic condition is teaching doctors a crucial lesson about misdiagnosis in infants.
Exploring the fascinating medical case where Growth Hormone therapy appears to trigger Juvenile Rheumatoid Arthritis in pediatric patients.
Discover how anti-LAM IgM antibodies act as cellular gatekeepers against tuberculosis by blocking bacterial invasion through innovative immune mechanisms.
Exploring Galectin-9 as a predictive marker for immune-related adverse effects in Adult T Cell Leukemia therapy
Explore the science behind antifungal drugs, their mechanisms, resistance development, and the future of fighting fungal infections.
Understanding treatment outcomes for HIV and TB co-infected pregnant women in Nigeria's resource-poor settings